Literature DB >> 20624124

Aptamer applications for targeted cancer therapy.

Andrew S Barbas1, Jing Mi, Bryan M Clary, Rebekah R White.   

Abstract

Aptamers are single-stranded DNA or RNA oligonucleotides that assume specific 3D structures and bind to target molecules with high affinity. The unique specificity of aptamers has made them attractive agents for targeted cancer therapy. Aptamers have been developed against a variety of cancer targets, including extracellular ligands and cell surface proteins. In addition, aptamers have been incorporated into novel constructs involving siRNAs, chemotherapeutic agents, cell toxins and nanoparticles, in which they function as delivery agents for therapeutic cargo. In this article, we review recent developments in the use of aptamers for targeted cancer therapy, particularly focusing on novel applications of aptamers targeting the cell surface.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624124     DOI: 10.2217/fon.10.67

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  26 in total

Review 1.  Managing diabetes with nanomedicine: challenges and opportunities.

Authors:  Omid Veiseh; Benjamin C Tang; Kathryn A Whitehead; Daniel G Anderson; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-11-28       Impact factor: 84.694

2.  Thermodynamics of ligand binding to a heterogeneous RNA population in the malachite green aptamer.

Authors:  Joshua E Sokoloski; Sarah E Dombrowski; Philip C Bevilacqua
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

Review 3.  Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.

Authors:  Omid Veiseh; Forrest M Kievit; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2011-02-02       Impact factor: 15.470

4.  Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.

Authors:  Nianxi Zhao; Sung-Nan Pei; Jianjun Qi; Zihua Zeng; Swaminathan P Iyer; Pei Lin; Ching-Hsuan Tung; Youli Zu
Journal:  Biomaterials       Date:  2015-07-15       Impact factor: 12.479

5.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

6.  Using distal-site mutations and allosteric inhibition to tune, extend, and narrow the useful dynamic range of aptamer-based sensors.

Authors:  Alessandro Porchetta; Alexis Vallée-Bélisle; Kevin W Plaxco; Francesco Ricci
Journal:  J Am Chem Soc       Date:  2012-12-13       Impact factor: 15.419

Review 7.  Multifunctional nanoparticles for drug delivery and molecular imaging.

Authors:  Gang Bao; Samir Mitragotri; Sheng Tong
Journal:  Annu Rev Biomed Eng       Date:  2013-04-29       Impact factor: 9.590

8.  Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

Authors:  Matthias T Stephan; Darrell J Irvine
Journal:  Nano Today       Date:  2011-06-01       Impact factor: 20.722

9.  Bifidobacterium bifidum-Mediated Specific Delivery of Nanoparticles for Tumor Therapy.

Authors:  Yu Tang; Chun Chen; Binglei Jiang; Lu Wang; Fujie Jiang; Disen Wang; Yaotai Wang; Haiyan Yang; Xia Ou; Yan Du; Qi Wang; Jianzhong Zou
Journal:  Int J Nanomedicine       Date:  2021-07-06

Review 10.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.